Covance
Home About Covance Investor Relations News Careers Contact Us
Home > Financial Info > Press Releases
 Advanced Search
Take me to...
Find a service
Drug Development Services
Nonclinical
Clinical
Commercialization
Industries We Serve
Biotech
Environmental
Food & Dietary Supplements
Pharma
Research
Vaccines
Antibody Products Store
Volunteer for a Study
Investigators
Information Library
Animal Welfare
COVANCE STRENGTHENS FOOD AND PRODUCT PACKAGING TESTING SERVICES
Princeton, New Jersey, December 17, 2002 — Covance Inc. (NYSE: CVD) is pleased to announce that Dr. Agnes Denes has joined the company as Staff Scientist and Study Director for Food and Product Packaging Testing Services at Covance. In this position, Dr. Denes will assume responsibility for both developing and conducting analyses, maintaining study documents and directly supporting clients. She comes to Covance with a strong academic history in cross-disciplinary research involving chemistry and bacteriology. Covance is a leader in offering Analytical Testing Services to the food, dietary supplement and biotechnology industries.

Dr. Denes brings six years of experience in both chemistry and analytical chemistry with a broad expertise in analytical techniques. Most recently, Dr. Denes was a Research Associate with the Food Research Institute and Department of Food Microbiology and Toxicology at the University of Wisconsin Madison where she oversaw various food-safety related studies. During that time she published multiple papers and presented posters at various conferences on the topic of surface modification of polymers for reducing bacterial biofilm deposition. She was also awarded the Gertrude Anthony Research Scholarship for research work in the area of cold-plasma induced surface modifications of synthetic polymers.

Dr. Denes received a Bachelor of Science degree in Physical Chemistry from the A.I. Cuza University in Iasi, Romania, a Masters of Science in Textile Chemistry, and a Doctoral degree in Wood Chemistry from the University of Wisconsin Madison.


Covance, with headquarters in Princeton, New Jersey, is one of the world's largest and most comprehensive drug development services companies with 2001 pro forma revenues of $800 million, operations currently in 17 countries, and approximately 6 ,900 employees worldwide. Information on Covance's products and services, recent press releases, and SEC filings can be obtained through the website in the About Covance area.
SEC Filings
Annual Reports
Quarterly Reports
Press Releases